Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Recent studies have suggested that serum levels of vascular endothelial growth factor (VEGF) may provide useful prognostic information in patients with various types of cancers. However, there has been a debate on whether serum VEGF level is a true reflection of tumor angiogenic activity in cancer patients. This debate originates from the finding that most VEGF in the serum is released from platelets during clotting. It has been postulated that platelet may serve the role of storage for circulating VEGF derived from the tumors. We conducted a study to clarify whether the platelet load of VEGF in the circulation correlates with tumor expression of VEGF. We measured quantitatively the serum VEGF(165) levels and tumor cytosolic VEGF(165) concentration by an ELISA and tumor VEGF(165) mRNA by real-time quantitative reverse transcription-PCR in 60 patients with hepatocellular carcinoma. Serum VEGF(165) levels correlated significantly with platelet counts (r = 0.662, P < 0.001). When corrected for platelet count, serum VEGF(165)/platelet correlated significantly with tumor cytosolic VEGF(165) concentration (r = 0.447, P = 0.006), which in turn correlated with VEGF(165) mRNA expression in the tumors (r = 0.315, P = 0.020). Advancing tumor stage was associated with a significant increase in tumor cytosolic VEGF(165) concentration (P = 0.006), tumor VEGF(165) mRNA expression (P = 0.012), serum VEGF(165)/platelet (P = 0.001), and serum VEGF(165) levels (P = 0.003). In conclusion, our data showed that the platelet load of VEGF in the circulation correlated positively with tumor VEGF expression. This study provides strong evidence that supports the use of serum VEGF level as an indirect estimate of tumor VEGF expression.
Poon
Ronnie Tung-Ping
RT
Centre for the Study of Liver Disease and Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, China. poontp@hkucc.hku.hk
Lau
Cecilia Pik-Yuk
CP
Cheung
Siu-Tim
ST
Yu
Wun-Ching
WC
Fan
Sheung-Tat
ST
D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000096:biosynthesis / Q000097:blood* / Q000235:genetics; D001777:Blood Coagulation; D001792:Blood Platelets / Q000737:chemistry* / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000098:blood supply / Q000235:genetics; D016228:Endothelial Growth Factors / Q000096:biosynthesis / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D008113:Liver Neoplasms / Q000097:blood* / Q000098:blood supply / Q000235:genetics; D008222:Lymphokines / Q000096:biosynthesis / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000097:blood / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D014408:Biomarkers, Tumor; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D009363:Neoplasm Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors